Spotlight on ALS: Mark Bonyhadi
Our Approach: The Cells
Generating Human Astrocyte Precursors for ALS Studies
Mark Bonyhadi, Ph.D. spoke at the “Spotlight on Disease Team Awards: ALS,” an educational event presented at the CIRM Governing Board meeting on June 23, 2010. Bonyhadi is director of clinical business development for cell therapy in the Cell Therapy Systems group at Invitrogen, part of Life Technologies.
The CIRM-hosted event was presented in San Diego, California.